Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 24, 2024 - Issue 4
Submit an article Journal homepage
272
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Effectiveness of biological therapy in reducing psoriasis-related cardiovascular risk

Sara Boskovica Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, ItalyCorrespondence[email protected]
View further author information
,
Silvia Borrielloa Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, ItalyView further author information
,
Fabrizio D’Ascenzob Department of Medical Sciences, Section of Cardiology, University of Turin, Turin, ItalyView further author information
,
Nadia Sciamarrellia Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, ItalyView further author information
,
Francois Rosseta Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, ItalyView further author information
,
Luca Mastorinoa Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, ItalyView further author information
,
Dapavo Paoloa Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, ItalyView further author information
,
Pier Paolo Bocchinob Department of Medical Sciences, Section of Cardiology, University of Turin, Turin, ItalyView further author information
,
Ovidio De Filippob Department of Medical Sciences, Section of Cardiology, University of Turin, Turin, ItalyView further author information
,
Simone Riberoa Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, ItalyView further author information
,
Gaetano De Ferrarib Department of Medical Sciences, Section of Cardiology, University of Turin, Turin, ItalyView further author information
&
Pietro Quaglinoa Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, ItalyView further author information
 show all
Pages 217-219 | Received 13 Dec 2023, Accepted 26 Mar 2024, Published online: 01 Apr 2024

References

  • Hu SC, Lan CE. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment. Int J Mol Sci. 2017 Oct 21 ;18(10):2211. doi: 10.3390/ijms18102211. PMID: 29065479; PMCID: PMC5666891.
  • Egeberg A, Gisondi P, Carrascosa JM, et al. The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1695–1706. doi: 10.1111/jdv.16273
  • Mastorino L, Castelli F, Stroppiana E, et al. Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e838–e841. doi: 10.1111/jdv.18314
  • Orlando G, Molon B, Viola A, et al. Psoriasis and cardiovascular diseases: an Immune-Mediated Cross Talk? Front Immunol. 2022 May 24;13:868277. doi: 10.3389/fimmu.2022.868277
  • Dey AK, Joshi AA, Chaturvedi A, et al. Association between skin and aortic vascular inflammation in patients with psoriasis: a case-cohort study using positron emission tomography/Computed tomography. JAMA Cardiol. 2017;2(9):1013–1018. doi: 10.1001/jamacardio.2017.1213
  • Armstrong AW, Voyles SV, Armstrong EJ, et al. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol. 2011 Jul;20(7):544–549.
  • Hwang J, Yoo JA, Yoon H, et al. The role of leptin in the association between obesity and psoriasis. Biomol Ther. 2021 Jan 1;29(1):11–21. doi: 10.4062/biomolther.2020.054
  • Ruiyang B, Panayi A, Ruifang W, et al. Adiponectin in psoriasis and its comorbidities: a review. Lipids Health Dis. 2021 Aug 9;20(1):87. doi: 10.1186/s12944-021-01510-z
  • Sanz-Martínez MT, Moga E, Sánchez Martínez MA, et al. High levels of platelet-lymphocyte complexes in patients with psoriasis are associated with a better response to anti-TNF-α therapy. J Invest Dermatol. 2020 Jun;140(6):1176–1183.
  • Kwon HJ, Coté TR, Cuffe MS, et al. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med. 2003;138(10):807–811. doi: 10.7326/0003-4819-138-10-200305200-00008
  • Lockshin B, Balagula Y, Merola JF. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. J Am Acad Dermatol. 2018 Aug;79(2):345–352. doi: 10.1016/j.jaad.2018.02.040
  • Koschitzky M, Navrazhina K, Garshick MS, et al. Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris. Exp Dermatol. 2022 Sep;31(9):1341–1351.
  • Gelfand JM, Shin DB, Alavi A, et al. A phase IV, randomized, double-blind, placebo-controlled crossover study of the effects of Ustekinumab on vascular inflammation in psoriasis (the VIP-U trial). J Invest Dermatol. 2020 Jan;140(1):85–93.e2.
  • Lerman JB, Joshi AA, Chaturvedi A, et al. Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study. Circulation. 2017 Jul 18;136(3):263–276. doi: 10.1161/CIRCULATIONAHA.116.026859
  • Visseren FLJ, Mach F, Smulders UM, et al. ESC Guidelines on cardiovascular disease prevention in clinical practice. Euro Hea Jou. 2021; 42(34): 3227–3337. doi: 10.1093/eurheartj/ehab484
  • Tamer F, Atliya OE, Aksakal AB. Triglyceride glucose index: a novel biomarker in the management of patients with psoriasis. Eur Rev Med Pharmacol Sci. 2023 Dec;27(23):11275–11280. doi: 10.26355/eurrev_202312_34566
  • Schlenker SM, Munhoz SI, Busanello AR, et al. Resistin serum levels and its association with clinical profile and carotid intima-media thickness in psoriasis: a cross-sectional study. An Bras Dermatol. 2023 Nov;98(6):799–805.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.